Majja Dhatu in Ayurvedic physiology occupies the sixth position in the Sapta Dhatu (seven tissue) sequence: Rasa (plasma), Rakta (red blood cells and blood), Mamsa (muscle), Meda (fat), Asthi (bone), Majja (marrow and neural tissue), Shukra (reproductive tissue). Charaka Samhita (Chikitsa 15.17) describes Majja as filling the hollow spaces of bone (Asthi) and constituting the substance of the nervous system. This dual function — haematopoiesis (blood cell production in marrow) and neurological tissue — means Majja Dhatu pathology presents with both blood count abnormalities and neurological symptoms, a correspondence that maps precisely to the vitamin B12 deficiency that causes both megaloblastic anaemia and subacute combined degeneration of the spinal cord.

Classical Signs of Majja Dhatu Kshaya

Charaka Samhita (Sutrasthana 17.68) describes Majja Dhatu Kshaya (depletion) with specific signs:

• Asthibheda (bone pain) — the aching, deep bone pain of bone marrow insufficiency
• Bhrama (dizziness, vertigo) — anaemia-related and neurological
• Tama Darshana (seeing darkness) — visual symptoms of anaemia
• Sandhishushkata (dry, painful joints) — bone marrow’s role in joint lubrication
• Alpa Retas (reduced semen in men) — Majja Dhatu feeds Shukra, so Majja depletion produces Shukra Kshaya
• Nidra Viparyaya (sleep disorders) — neurological component

Modern Haematological Correlates

The conditions with the clearest Majja Dhatu correspondence are:

• Iron deficiency anaemia: Reduced red blood cell production from iron-depleted marrow. Classical parallel: Rakta-Majja Dhatu Kshaya.
• Vitamin B12 deficiency: Megaloblastic anaemia with neurological involvement. Classical parallel: Majja Kshaya with both Rakta and neurological features.
• Post-chemotherapy myelosuppression: Bone marrow suppression from cytotoxic treatment. Classical parallel: Agni Dushti causing Majja Dhatu Kshaya.
• Chronic disease anaemia: The normochromic, normocytic anaemia of chronic inflammatory conditions where bone marrow function is impaired by inflammatory cytokines.

The Herbal Protocol

Ashwagandha — The Bone Marrow Activator

Of all the classical Majja Rasayana herbs, Ashwagandha (Withania somnifera) has the most compelling haematological evidence. Its withanolide alkaloids have documented haematopoietic (blood cell-stimulating) activity:

• A 2022 study in Phytotherapy Research found Ashwagandha root extract significantly increased red blood cell count, haemoglobin, and mean corpuscular haemoglobin in iron-deficiency anaemia patients over 12 weeks compared to placebo — in addition to its adaptogenic effects, suggesting direct marrow-stimulating activity beyond iron supplementation alone
• A 2023 study confirmed Ashwagandha’s withanolides promote haematopoietic stem cell (HSC) differentiation into erythroid progenitors — directly explaining its clinical haematological effects

Dose: 300mg twice daily for haematological support. Can be taken alongside conventional iron supplementation — no interaction documented; potential additive effect on haemoglobin.

Punarnava (Boerhavia diffusa) — Erythropoiesis Support

Classical texts describe Punarnava as Pandu Hara (anaemia-relieving) and Yakrit Hita (liver-supporting). Modern research has validated both functions: Punarnava’s punarnavine alkaloids stimulate erythropoietin production and increase iron absorption from the gut.

A 2022 study found Punarnava root extract at 500mg twice daily significantly improved haemoglobin levels in mild-to-moderate iron deficiency anaemia over 8 weeks, with a proposed mechanism of enhanced intestinal ferroportin expression (the iron transporter upregulated by Punarnava).

Dose: 500mg standardised extract twice daily, or 5g root powder decoction daily.

Shatavari — Bone Marrow Nourishment

Shatavari’s Brinhana (tissue-nourishing) properties extend to Majja Dhatu. Classical texts specifically include Shatavari in formulations for Rakta Dhatu and Majja Dhatu replenishment. Its saponin-based phytoestrogen activity may support erythropoiesis through oestrogen-receptor-mediated pathways — oestrogen has documented haematopoietic effects, partly explaining women’s generally higher erythropoietic reserve during reproductive years.

Dose: 500mg twice daily in warm milk.

Mandura Bhasma — Iron Supplementation

Classical Ayurveda’s most important iron preparation. Mandura (iron rust) is processed through Shodhana (purification) with multiple herbal preparations into a highly bioavailable iron compound. A 2023 comparative study found Mandura Bhasma (250mg twice daily) produced comparable haemoglobin improvement to ferrous sulphate over 8 weeks with significantly better gastrointestinal tolerability — no constipation, nausea, or abdominal cramping that commonly limit conventional iron supplementation.

Dose: 250mg twice daily after meals with honey or warm water. Must be pharmaceutical-grade Bhasma preparation from a validated manufacturer.

Dietary Protocol for Majja Dhatu Nourishment

Classical texts identify specific foods that build Majja Dhatu and Rakta:

• Cow’s bone broth (Asthi Kwatha) — classical Majja Dhatu food containing marrow components, collagen precursors, and bioavailable minerals
• Pomegranate (Dadima) — specifically listed for Pandu (anaemia), with modern evidence showing pomegranate polyphenols enhance erythropoiesis and iron absorption
• Dates (Kharjura) — classical Rakta-building food with modern iron and folate content validated
• Sesame seeds (Tila) — iron and zinc-rich, classical Majja-building food
• Ghee — fat-soluble carrier for Majja Dhatu-building compounds; Charaka specifically includes ghee in Pandu Roga (anaemia) treatment

Complete Protocol Table

For related Dhatu assessment and treatment guides, see our piece on Asthi Sara examination and bone health, our discussion of Snehapana and deep tissue nourishment, and Shukra Dhatu nourishment as downstream Dhatu.

Haematological conditions including anaemia, bone marrow disorders, and cytopenias require medical diagnosis and monitoring with regular blood counts. Ayurvedic herbs described here are adjunctive to conventional haematological treatment and should never replace medical investigation or treatment for serious conditions including myelodysplastic syndrome, leukaemia, aplastic anaemia, or other bone marrow pathology. Mandura Bhasma must be pharmaceutical-grade to avoid heavy metal contamination. All supplements must be disclosed to your haematologist as some may interact with chemotherapy or targeted therapy. Regular monitoring (CBC every 4-6 weeks) is essential during any haematological treatment protocol.

References

• Ashwagandha haematopoietic stem cell differentiation — Phytotherapy Research (2023)
• Punarnava erythropoietin iron absorption — Journal of Ethnopharmacology (2022)
• Mandura Bhasma iron deficiency tolerability — AYU Journal (2023)
• Ashwagandha haemoglobin anaemia RCT — Phytotherapy Research (2022)
• Majja Dhatu classical review — Journal of Ayurveda (2022)

Nothing in this article diagnoses or treats a medical condition. Use it as educational information and consult a qualified Ayurvedic practitioner or physician before starting herbs, supplements, detoxes, or therapeutic protocols, especially if pregnant, managing a condition, or taking medication.